Bristol-Myers Squibb Company (LON:0R1F)
London · Delayed Price · Currency is GBP · Price in USD 54.86
-0.07 (-0.13%)
At close: Jan 30, 2026
LON:0R1F Market Cap
LON:0R1F has a market cap or net worth of 81.69 billion as of January 30, 2026. Its market cap has decreased by -11.84% in one year.
Market Cap
81.69B
Enterprise Value
106.60B
Revenue
35.73B
Ranking
n/a
PE Ratio
18.18
Stock Price
54.86
Market Cap Chart
Since January 2, 1968, LON:0R1F's market cap has increased from 2.14B to 81.69B, an increase of 3,713.28%. That is a compound annual growth rate of 6.47%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 30, 2026 | 81.69B | 0.12% |
| Dec 31, 2025 | 81.59B | -10.96% |
| Dec 31, 2024 | 91.63B | 11.79% |
| Dec 29, 2023 | 81.97B | -38.16% |
| Dec 30, 2022 | 132.55B | 29.68% |
| Dec 31, 2021 | 102.21B | -0.45% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 210.92B |
| GSK plc | 75.29B |
| Haleon | 33.75B |
| Smith & Nephew | 10.55B |
| Convatec Group | 4.48B |
| Hikma Pharmaceuticals | 3.39B |
| Genus | 2.11B |
| HUTCHMED (China) | 1.89B |